Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
014440.KS Stock Summary
Top 10 Correlated ETFs
014440.KS
In the News
014440.KS Financial details
Company Rating
Strong Buy
Market Cap
67.37B
Income
5.96B
Revenue
90.28B
Book val./share
8403.28
Cash/share
2117.94
Dividend
50
Dividend %
1.37%
Employees
236
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
12.57
Forward P/E
-
PEG
-11.6
P/S
0.81
P/B
0.44
P/C
1.69
P/FCF
16.54
Quick Ratio
-
Current Ratio
5.1
Debt / Equity
0.01
LT Debt / Equity
0
-
-
EPS (TTM)
305.88
EPS next Y
-
EPS next Q
-
EPS this Y
-10.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.05%
Revenue last 5Y
-7.2%
Revenue Q/Q
20.17%
EPS Q/Q
828.63%
-
-
-
-
SMA20
-2.6%
SMA50
-5.72%
SMA100
4.33%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.01%
Gross Margin
22%
Oper. Margin
1%
Profit Margin
6%
Payout
-
Shs Outstand
19.5M
Shs Float
9.07M
-
-
-
-
Target Price
-
52W Range
3140.0-4490.0
52W High
-20.16%
52W Low
+14.17%
RSI
61.27
Rel Volume
6.64
Avg Volume
41.58K
Volume
276.14K
Perf Week
5.44%
Perf Month
0%
Perf Quarter
9.97%
Perf Half Y
9.97%
-
-
-
-
Beta
1.21
-
-
Volatility
66.11%, 82.46%
Prev Close
0.7%
Price
3585
Change
-6.52%
014440.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.74K | 5.51K | 5.13K | 4.26K | 4.63K | |
Net income per share | 263 | 145.75 | 180 | 343.04 | 305.68 | |
Operating cash flow per share | 231.59 | 465.93 | 868.83 | 513.31 | 842.23 | |
Free cash flow per share | -249.43 | 139.35 | 419.11 | -84.88 | 551.74 | |
Cash per share | 1.63K | 1.45K | 1.44K | 1.98K | 2.12K | |
Book value per share | 7.47K | 7.57K | 7.98K | 8.12K | 8.4K | |
Tangible book value per share | 7.26K | 7.32K | 7.7K | 8K | 8.3K | |
Share holders equity per share | 7.47K | 7.57K | 7.98K | 8.12K | 8.4K | |
Interest debt per share | 651.64 | 483.57 | 470.16 | 508.68 | 119.89 | |
Market cap | 67.85B | 72.25B | 86.08B | 64.06B | 73.61B | |
Enterprise value | 48.61B | 53.05B | 59.07B | 35.21B | 39.56B | |
P/E ratio | 13.25 | 25.42 | 24.58 | 9.58 | 12.35 | |
Price to sales ratio | 0.52 | 0.67 | 0.86 | 0.77 | 0.82 | |
POCF ratio | 15.05 | 7.95 | 5.09 | 6.4 | 4.48 | |
PFCF ratio | -13.97 | 26.59 | 10.56 | -38.7 | 6.84 | |
P/B Ratio | 0.47 | 0.49 | 0.55 | 0.4 | 0.45 | |
PTB ratio | 0.47 | 0.49 | 0.55 | 0.4 | 0.45 | |
EV to sales | 0.37 | 0.49 | 0.59 | 0.42 | 0.44 | |
Enterprise value over EBITDA | 2.72 | 3.66 | 3.79 | 2.67 | 2.59 | |
EV to operating cash flow | 10.78 | 5.84 | 3.49 | 3.52 | 2.41 | |
EV to free cash flow | -10.01 | 19.52 | 7.25 | -21.27 | 3.68 | |
Earnings yield | 0.08 | 0.04 | 0.04 | 0.1 | 0.08 | |
Free cash flow yield | -0.07 | 0.04 | 0.09 | -0.03 | 0.15 | |
Debt to equity | 0.09 | 0.06 | 0.06 | 0.06 | 0.01 | |
Debt to assets | 0.07 | 0.05 | 0.05 | 0.05 | 0.01 | |
Net debt to EBITDA | -1.08 | -1.32 | -1.73 | -2.19 | -2.23 | |
Current ratio | 2.27 | 2.69 | 3.1 | 3.5 | 5.22 | |
Interest coverage | 36.37 | 12.78 | 24.46 | 26.2 | 72.85 | |
Income quality | 0.95 | 3.42 | 4.83 | 1.5 | 2.7 | |
Dividend Yield | 0.03 | 0.03 | 0.02 | 0.03 | 0.01 | |
Payout ratio | 0.38 | 0.71 | 0.42 | 0.29 | 0.16 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | -0.02 | 0.02 | |
Research and developement to revenue | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | |
Capex to operating cash flow | -2.08 | -0.7 | -0.52 | -1.17 | -0.34 | |
Capex to revenue | -0.07 | -0.06 | -0.09 | -0.14 | -0.06 | |
Capex to depreciation | -1.07 | -0.67 | -0.99 | -1.35 | -0.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.65K | 4.98K | 5.68K | 7.92K | 7.6K | |
ROIC | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 | |
Return on tangible assets | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | |
Graham Net | 1.42K | 1.61K | 1.55K | 2.13K | 2.6K | |
Working capital | 42.73B | 45.91B | 51.64B | 54.03B | 63.86B | |
Tangible asset value | 141.34B | 142.78B | 149.73B | 156.06B | 161.9B | |
Net current asset value | 42.21B | 45.86B | 51.56B | 53.66B | 63.82B | |
Invested capital | 0.09 | 0.06 | 0.06 | 0.06 | 0.01 | |
Average receivables | 31.97B | 31.38B | 29.11B | 26.01B | 25.77B | |
Average payables | 12.93B | 10.47B | 9.04B | 7.15B | 6.46B | |
Average inventory | 12.56B | 13.29B | 13.43B | 12.71B | 10.88B | |
Days sales outstanding | 86.61 | 107.51 | 97.34 | 111.76 | 105.68 | |
Days payables outstanding | 41 | 42.64 | 40.54 | 34.53 | 37.83 | |
Days of inventory on hand | 49.18 | 57.53 | 66.57 | 67.98 | 54.52 | |
Receivables turnover | 4.21 | 3.4 | 3.75 | 3.27 | 3.45 | |
Payables turnover | 8.9 | 8.56 | 9 | 10.57 | 9.65 | |
Inventory turnover | 7.42 | 6.34 | 5.48 | 5.37 | 6.69 | |
ROE | 0.04 | 0.02 | 0.02 | 0.04 | 0.04 | |
Capex per share | -481.01 | -326.59 | -449.72 | -598.19 | -290.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.26K | 1.03K | 1.11K | 1.13K | 1.36K | |
Net income per share | 179.12 | 36.21 | 55 | 20.89 | 193.99 | |
Operating cash flow per share | 10.36 | 326.26 | 280.09 | -12.8 | 250.75 | |
Free cash flow per share | -87.15 | 282 | 211.57 | -89.98 | 149.7 | |
Cash per share | 1.98K | 2.02K | 2.12K | 1.99K | 2.12K | |
Book value per share | 8.12K | 8.2K | 8.27K | 8.27K | 8.4K | |
Tangible book value per share | 8K | 8.08K | 8.16K | 8.17K | 8.3K | |
Share holders equity per share | 8.12K | 8.2K | 8.27K | 8.27K | 8.4K | |
Interest debt per share | 502.04 | 244.89 | 202.33 | 146.66 | 115.56 | |
Market cap | 64.06B | 69.42B | 75.88B | 64.74B | 73.61B | |
Enterprise value | 35.21B | 34.71B | 51.81B | 33.68B | 39.56B | |
P/E ratio | 4.58 | 24.58 | 17.82 | 39.73 | 4.87 | |
Price to sales ratio | 2.6 | 3.44 | 3.53 | 2.93 | 2.77 | |
POCF ratio | 317 | 10.91 | 14 | -259.39 | 15.06 | |
PFCF ratio | -37.69 | 12.62 | 18.53 | -36.9 | 25.22 | |
P/B Ratio | 0.4 | 0.43 | 0.47 | 0.4 | 0.45 | |
PTB ratio | 0.4 | 0.43 | 0.47 | 0.4 | 0.45 | |
EV to sales | 1.43 | 1.72 | 2.41 | 1.52 | 1.49 | |
Enterprise value over EBITDA | 25.55 | 10.85 | 16.14 | 7.35 | 5.48 | |
EV to operating cash flow | 174.22 | 5.46 | 9.56 | -134.96 | 8.09 | |
EV to free cash flow | -20.72 | 6.31 | 12.65 | -19.2 | 13.55 | |
Earnings yield | 0.05 | 0.01 | 0.01 | 0.01 | 0.05 | |
Free cash flow yield | -0.03 | 0.08 | 0.05 | -0.03 | 0.04 | |
Debt to equity | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | |
Debt to assets | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | |
Net debt to EBITDA | -20.94 | -10.85 | -7.5 | -6.78 | -4.72 | |
Current ratio | 3.5 | 4.28 | 4.54 | 5.1 | 5.22 | |
Interest coverage | -13.11 | 25.21 | 43.46 | 7.74 | 479.66 | |
Income quality | 0.06 | 9.01 | 5.09 | -0.61 | 1.25 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.92 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.2 | 0.02 | |
Research and developement to revenue | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -9.41 | -0.14 | -0.24 | 6.03 | -0.4 | |
Capex to revenue | -0.08 | -0.04 | -0.06 | -0.07 | -0.07 | |
Capex to depreciation | -0.88 | -0.4 | -0.63 | -0.73 | -1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.72K | 2.58K | 3.2K | 1.97K | 6.06K | |
ROIC | -0.01 | 0 | 0.01 | 0 | 0.03 | |
Return on tangible assets | 0.02 | 0 | 0.01 | 0 | 0.02 | |
Graham Net | 2.13K | 2.24K | 2.37K | 2.44K | 2.6K | |
Working capital | 54.03B | 56.18B | 56.9B | 59.01B | 63.86B | |
Tangible asset value | 156.06B | 157.54B | 157.85B | 159.25B | 161.9B | |
Net current asset value | 53.66B | 55.17B | 56.8B | 58.97B | 63.82B | |
Invested capital | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | |
Average receivables | 24.76B | 23.73B | 21.21B | 21.9B | 24.79B | |
Average payables | 6.28B | 5.83B | 5.99B | 6.1B | 6.47B | |
Average inventory | 12.87B | 11.75B | 11.73B | 11.35B | 10.58B | |
Days sales outstanding | 92.79 | 98.51 | 85.37 | 95.44 | 88.57 | |
Days payables outstanding | 28.42 | 32.56 | 34.23 | 30.58 | 35.6 | |
Days of inventory on hand | 55.94 | 67.17 | 63.69 | 56.89 | 51.3 | |
Receivables turnover | 0.97 | 0.91 | 1.05 | 0.94 | 1.02 | |
Payables turnover | 3.17 | 2.76 | 2.63 | 2.94 | 2.53 | |
Inventory turnover | 1.61 | 1.34 | 1.41 | 1.58 | 1.75 | |
ROE | 0.02 | 0 | 0.01 | 0 | 0.02 | |
Capex per share | -97.52 | -44.25 | -68.52 | -77.18 | -101.05 |
014440.KS Frequently Asked Questions
What is Youngbo Chemical Co., Ltd. stock symbol ?
Youngbo Chemical Co., Ltd. is a KR stock and trading under the symbol 014440.KS
What is Youngbo Chemical Co., Ltd. stock quote today ?
Youngbo Chemical Co., Ltd. stock price is $3585 today.
Is Youngbo Chemical Co., Ltd. stock public?
Yes, Youngbo Chemical Co., Ltd. is a publicly traded company.